Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey.

Katalin PungorJennifer LeeTom R Denee Yerkebulan KambarovRiikka NissinenKevin AmpehMarco Pellegrini Francesco Parmeggiani

Published in: Advances in therapy (2024)

The diagnosis, genetic testing, and management pathways among patients with XLRP can vary considerably. There is a need for more standardized diagnosis and management pathways, and QoL assessments, due to the major impact that XLRP has on patients' lives.

Keyphrases

cross sectional
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
primary care
peritoneal dialysis
prognostic factors
patient reported outcomes